These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15093254)

  • 41. [Immunotoxicity and pathogenicity of substances].
    van den Tweel JG
    Ned Tijdschr Geneeskd; 1992 Oct; 136(40):1949-51. PubMed ID: 1407175
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. International Conference on Harmonisation; Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Apr; 71(71):19193-4. PubMed ID: 16612859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune function tests for hazard identification: a paradigm shift in drug development.
    Gore ER
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):331-5. PubMed ID: 16623854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunotoxicity of monoclonal antibodies.
    Descotes J
    MAbs; 2009; 1(2):104-11. PubMed ID: 20061816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunomodulation by fungal toxins.
    Bondy GS; Pestka JJ
    J Toxicol Environ Health B Crit Rev; 2000; 3(2):109-43. PubMed ID: 10834078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
    Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What's so special about the developing immune system?
    Burns-Naas LA; Hastings KL; Ladics GS; Makris SL; Parker GA; Holsapple MP
    Int J Toxicol; 2008; 27(2):223-54. PubMed ID: 18404545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of SRBC antibody responses for immunotoxicity testing.
    Ladics GS
    Methods; 2007 Jan; 41(1):9-19. PubMed ID: 17161298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
    Brent RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Species comparison of anatomical and functional immune system development.
    Holsapple MP; West LJ; Landreth KS
    Birth Defects Res B Dev Reprod Toxicol; 2003 Aug; 68(4):321-34. PubMed ID: 14666995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of autoimmunity by pharmaceuticals.
    Pieters R
    Methods; 2007 Jan; 41(1):112-7. PubMed ID: 17161307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Developmental immunotoxicology of lead.
    Dietert RR; Lee JE; Hussain I; Piepenbrink M
    Toxicol Appl Pharmacol; 2004 Jul; 198(2):86-94. PubMed ID: 15236947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design and evaluation of immunotoxicity studies.
    Roth DR; Roman D; Ulrich P; Mahl A; Junker U; Perentes E
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):367-71. PubMed ID: 16709448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning.
    Levy A; Cohen G; Gilat E; Kapon J; Dachir S; Abraham S; Herskovitz M; Teitelbaum Z; Raveh L
    Arch Toxicol; 2007 May; 81(5):353-9. PubMed ID: 17009047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunotoxicity evaluation by immune function tests: focus on the T-dependent antibody response (TDAR) [Overview of a Workshop Session at the 45th Annual Meeting of the Society of Toxicology (SOT) March 5-9, 2006 San Diego, CA].
    Herzyk DJ; Holsapple M
    J Immunotoxicol; 2007 Apr; 4(2):143-7. PubMed ID: 18958722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can infections protect against autoimmunity?
    Gaisford W; Cooke A
    Curr Opin Rheumatol; 2009 Jul; 21(4):391-6. PubMed ID: 19412105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunological disorders in men exposed to metallic mercury vapour. A review.
    Moszczyński P
    Cent Eur J Public Health; 1999 Feb; 7(1):10-4. PubMed ID: 10084014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.